Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Experimental and Therapeutic Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-0981 Online ISSN: 1792-1015
Journal Cover
June-2022 Volume 23 Issue 6

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
June-2022 Volume 23 Issue 6

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article

Targeting TNFα‑mediated cytotoxicity using thalidomide after experimental cardiac arrest in rats: An exploratory study

  • Authors:
    • Abigail A. Palmer
    • Jason P. Stezoski
    • Keri Janesko‑Feldman
    • Patrick M. Kochanek
    • Tomas Drabek
  • View Affiliations / Copyright

    Affiliations: Safar Center for Resuscitation Research, University of Pittsburgh School of Medicine, Pittsburgh, PA 15224, USA
  • Article Number: 380
    |
    Published online on: April 8, 2022
       https://doi.org/10.3892/etm.2022.11307
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Cardiac arrest (CA) results in a central and systemic cytokine and inflammatory response. Thalidomide has been reported to be neuroprotective by selectively decreasing TNFα synthesis. We hypothesized that thalidomide would decrease the systemic and organ‑specific TNFα/cytokine response and biomarkers of injury in rats subjected to 10 min CA. Naïves, CA treated with vehicle (CA) and CA treated with thalidomide (50 mg/kg; CA+T) were studied (n=6 per group). TNFα and key cytokines were assessed at 3 h after resuscitation in the cortex, hippocampus, striatum, cerebellum, plasma, heart and lung. Neuron specific enolase (NSE), S100b, cardiac troponin T (cTnT) and intestinal fatty acid binding protein (IFABP) were used to assess neuronal, glial, cardiac and intestinal damage, respectively. CA increased TNFα and multiple pro‑inflammatory cytokines in plasma and selected tissues with no differences between the CA and CA+T groups in any region. NSE, S100b, cTnT and IFABP were increased after CA or CA+T vs. in the naïve group (all P<0.05) without significant differences between the CA and CA+T groups. In conclusion, CA resulted in a TNFα and cytokine response, with increased biomarkers of organ injury. Notably, thalidomide at a dose reported to improve the outcome in in vivo models of brain ischemia did not decrease TNFα or cytokine levels in plasma, brain or extracerebral organs, or biomarkers of injury. Although CA at 3 h post resuscitation produces a robust TNFα response, it cannot be ruled out that an alternative dosing regimen or assessment at other time‑points might yield different results. The marked systemic and regional cytokine response to CA remains a potential therapeutic target.
View Figures

Figure 1

Figure 2

View References

1 

Janata A, Drabek T, Magnet IA, Stezoski JP, Janesko-Feldman K, Popp E, Garman RH, Tisherman SA and Kochanek PM: Extracorporeal versus conventional cardiopulmonary resuscitation after ventricular fibrillation cardiac arrest in rats: A feasibility trial. Crit Care Med. 41:e211–e222. 2013.PubMed/NCBI View Article : Google Scholar

2 

Badiola N, Malagelada C, Llecha N, Hidalgo J, Comella JX, Sabriá J and Rodríguez-Alvarez J: Activation of caspase-8 by tumour necrosis factor receptor 1 is necessary for caspase-3 activation and apoptosis in oxygen-glucose deprived cultured cortical cells. Neurobiol Dis. 35:438–447. 2009.PubMed/NCBI View Article : Google Scholar

3 

Liu Q, Qiu J, Liang M, Golinski J, van Leyen K, Jung JE, You Z, Lo EH, Degterev A and Whalen MJ: Akt and mTOR mediate programmed necrosis in neurons. Cell Death Dis. 5(e1084)2014.PubMed/NCBI View Article : Google Scholar

4 

Wang W, Xie L, Zou X, Hu W, Tian X, Zhao G and Chen M: Pomelo peel oil suppresses TNF-α-induced necroptosis and cerebral ischaemia-reperfusion injury in a rat model of cardiac arrest. Pharm Biol. 59:401–409. 2021.PubMed/NCBI View Article : Google Scholar

5 

Niemann JT, Youngquist ST, Shah AP, Thomas JL and Rosborough JP: TNF-α blockade improves early post-resuscitation survival and hemodynamics in a swine model of ischemic ventricular fibrillation. Resuscitation. 84:103–107. 2013.PubMed/NCBI View Article : Google Scholar

6 

Janata A, Magnet IA, Uray T, Stezoski JP, Janesko-Feldman K, Tisherman SA, Kochanek PM and Drabek T: Regional TNFα mapping in the brain reveals the striatum as a neuroinflammatory target after ventricular fibrillation cardiac arrest in rats. Resuscitation. 85:694–701. 2014.PubMed/NCBI View Article : Google Scholar

7 

Drabek T, Wilson CD, Janata A, Stezoski JP, Janesko-Feldman K, Garman RH, Tisherman SA and Kochanek PM: Unique brain region-dependent cytokine signatures after prolonged hypothermic cardiac arrest in rats. Ther Hypothermia Temp Manag. 5:26–39. 2015.PubMed/NCBI View Article : Google Scholar

8 

Uray T, Dezfulian C, Palmer AA, Miner KM, Leak RK, Stezoski JP, Janesko-Feldman K, Kochanek PM and Drabek T: Cardiac arrest induced by asphyxia versus ventricular fibrillation elicits comparable early changes in cytokine levels in the rat brain, heart, and serum. J Am Heart Assoc. 10(e018657)2021.PubMed/NCBI View Article : Google Scholar

9 

Janata A, Magnet IA, Schreiber KL, Wilson CD, Stezoski JP, Janesko-Feldman K, Kochanek PM and Drabek T: Minocycline fails to improve neurologic and histologic outcome after ventricular fibrillation cardiac arrest in rats. World J Crit Care Med. 8:106–119. 2019.PubMed/NCBI View Article : Google Scholar

10 

Huang YJ, Liao JF and Tsai TH: Concurrent determination of thalidomide in rat blood, brain and bile using multiple microdialysis coupled to liquid chromatography. Biomed Chromatogr. 19:488–493. 2005.PubMed/NCBI View Article : Google Scholar

11 

Sampaio EP, Sarno EN, Galilly R, Cohn ZA and Kaplan G: Thalidomide selectively inhibits tumor necrosis factor alpha production by stimulated human monocytes. J Exp Med. 173:699–703. 1991.PubMed/NCBI View Article : Google Scholar

12 

Klausner JD, Freedman VH and Kaplan G: Thalidomide as an anti-TNF-alpha inhibitor: Implications for clinical use. Clin Immunol Immunopathol. 81:219–223. 1996.PubMed/NCBI View Article : Google Scholar

13 

Alam HB: Translational barriers and opportunities for emergency preservation and resuscitation in severe injuries. Br J Surg. 99 (Suppl 1):S29–S39. 2012.PubMed/NCBI View Article : Google Scholar

14 

Majumder S, Sreedhara SR, Banerjee S and Chatterjee S: TNF α signaling beholds thalidomide saga: A review of mechanistic role of TNF-α signaling under thalidomide. Curr Top Med Chem. 12:1456–1467. 2012.PubMed/NCBI View Article : Google Scholar

15 

Zhang L, Qu Y, Tang J, Chen D, Fu X, Mao M and Mu D: PI3K/Akt signaling pathway is required for neuroprotection of thalidomide on hypoxic-ischemic cortical neurons in vitro. Brain Res. 1357:157–165. 2010.PubMed/NCBI View Article : Google Scholar

16 

Jung YJ, Tweedie D, Scerba MT and Greig NH: Neuroinflammation as a factor of neurodegenerative disease: Thalidomide analogs as treatments. Front Cell Dev Biol. 7(313)2019.PubMed/NCBI View Article : Google Scholar

17 

Nora GJ, Harun R, Fine DF, Hutchison D, Grobart AC, Stezoski JP, Munoz MJ, Kochanek PM, Leak RK, Drabek T and Wagner AK: Ventricular fibrillation cardiac arrest produces a chronic striatal hyperdopaminergic state that is worsened by methylphenidate treatment. J Neurochem. 142:305–322. 2017.PubMed/NCBI View Article : Google Scholar

18 

Andrade P, Visser-Vandewalle V, Del Rosario JS, Daemen MA, Buurman WA, Steinbusch HW and Hoogland G: The thalidomide analgesic effect is associated with differential TNF-α receptor expression in the dorsal horn of the spinal cord as studied in a rat model of neuropathic pain. Brain Res. 1450:24–32. 2012.PubMed/NCBI View Article : Google Scholar

19 

Choi JI, Kim WM, Yoon MH and Lee HG: Antiallodynic effect of thalidomide and morphine on rat spinal nerve ligation-induced neuropathic pain. Korean J Pain. 23:172–178. 2010.PubMed/NCBI View Article : Google Scholar

20 

Hyakkoku K, Nakajima Y, Izuta H, Shimazawa M, Yamamoto T, Shibata N and Hara H: Thalidomide protects against ischemic neuronal damage induced by focal cerebral ischemia in mice. Neuroscience. 159:760–769. 2009.PubMed/NCBI View Article : Google Scholar

21 

Ribeiro RA, Vale ML, Ferreira SH and Cunha FQ: Analgesic effect of thalidomide on inflammatory pain. Eur J Pharmacol. 391:97–103. 2000.PubMed/NCBI View Article : Google Scholar

22 

Saito K, Suyama K, Nishida K, Sei Y and Basile AS: Early increases in TNF-alpha, IL-6 and IL-1 beta levels following transient cerebral ischemia in gerbil brain. Neurosci Lett. 206:149–152. 1996.PubMed/NCBI View Article : Google Scholar

23 

Ryu JK and McLarnon JG: Thalidomide inhibition of perturbed vasculature and glial-derived tumor necrosis factor-alpha in an animal model of inflamed Alzheimer's disease brain. Neurobiol Dis. 29:254–266. 2008.PubMed/NCBI View Article : Google Scholar

24 

Liu T, Clark RK, McDonnell PC, Young PR, White RF, Barone FC and Feuerstein GZ: Tumor necrosis factor-alpha expression in ischemic neurons. Stroke. 25:1481–1488. 1994.PubMed/NCBI View Article : Google Scholar

25 

Pettigrew LC, Kindy MS, Scheff S, Springer JE, Kryscio RJ, Li Y and Grass DS: Focal cerebral ischemia in the TNFalpha-transgenic rat. J Neuroinflammation. 5(47)2008.PubMed/NCBI View Article : Google Scholar

26 

Ryu JK, Jantaratnotai N and McLarnon JG: Thalidomide inhibition of vascular remodeling and inflammatory reactivity in the quinolinic acid-injected rat striatum. Neuroscience. 163:601–608. 2009.PubMed/NCBI View Article : Google Scholar

27 

Schroeder DC, Maul AC, Mahabir E, Koxholt I, Yan X, Padosch SA, Herff H, Bultmann-Mellin I, Sterner-Kock A, Annecke T, et al: Evaluation of small intestinal damage in a rat model of 6 Minutes cardiac arrest. BMC Anesthesiol. 18(61)2018.PubMed/NCBI View Article : Google Scholar

28 

Wender M, Michalowska-Wender G and Szczech J: Minimal changes of TNF-alpha and MCP-1 expression in blood serum of rats subjected to experimental cardiac arrest. Folia Neuropathol. 43:109–111. 2005.PubMed/NCBI

29 

Yang M, Hua T, Yang Z, Chen L, Zou Y, Huang X and Li J: The protective effect of rhBNP on postresuscitation myocardial dysfunction in a rat cardiac arrest model. Biomed Res Int. 2020(6969053)2020.PubMed/NCBI View Article : Google Scholar

30 

Niemann JT, Rosborough JP, Youngquist S, Shah AP, Lewis RJ, Phan QT and Filler SG: Cardiac function and the proinflammatory cytokine response after recovery from cardiac arrest in swine. J Interferon Cytokine Res. 29:749–758. 2009.PubMed/NCBI View Article : Google Scholar

31 

Youngquist ST, Shah AP, Rosborough JP and Niemann JT: High serum tumor necrosis factor levels in the early post-cardiac arrest period are associated with poor short-term survival in a swine model of ventricular fibrillation. J Interferon Cytokine Res. 36:575–579. 2016.PubMed/NCBI View Article : Google Scholar

32 

Zhu F, Zhong X, Zhou Y, Hou Z, Hu H, Liang L, Chen J, Chen Q, Ji X and Shang D: Protective effects of nicorandil against cerebral injury in a swine cardiac arrest model. Exp Ther Med. 16:37–44. 2018.PubMed/NCBI View Article : Google Scholar

33 

Camara-Lemarroy CR, Guzman-de la Garza FJ, Alarcon-Galvan G, Cordero-Perez P, Munoz-Espinosa LE and Fernandez-Garza NE: Effects of thalidomide and pentoxyphylline over local and remote organ injury after intestinal ischemia/reperfusion. Transplant Proc. 42:1624–1626. 2010.PubMed/NCBI View Article : Google Scholar

34 

Fernandez-Martinez E, Morales-Rios MS, Perez-Alvarez V and Muriel P: Immunomodulatory effects of thalidomide analogs on LPS-induced plasma and hepatic cytokines in the rat. Biochem Pharmacol. 68:1321–1329. 2004.PubMed/NCBI View Article : Google Scholar

35 

Ilhan N, Susam S, Gul HF, Bardas R and Ilhan N: Which one is more effective for the treatment of rat sepsis model: Thalidomide or etanercept? Bratisl Lek Listy. 118:283–287. 2017.PubMed/NCBI View Article : Google Scholar

36 

Mohammed RA, El-Yamany MF, Abdel-Rahman AA, Nassar NN and Al-Shorbagy MY: Role of pERK1/2-NFĸB signaling in the neuroprotective effect of thalidomide against cerebral ischemia reperfusion injury in rats. Eur J Pharmacol. 895(173872)2021.PubMed/NCBI View Article : Google Scholar

37 

Lin CT, Lecca D, Yang LY, Luo W, Scerba MT, Tweedie D, Huang PS, Jung YJ, Kim DS, Yang CH, et al: 3,6'-dithiopomalidomide reduces neural loss, inflammation, behavioral deficits in brain injury and microglial activation. Elife. 9(e54726)2020.PubMed/NCBI View Article : Google Scholar

38 

Batsaikhan B and Wang JY, Scerba MT, Tweedie D, Greig NH, Miller JP, Hoffer BJ, Lin CT and Wang JY: Post-injury neuroprotective effects of the thalidomide Analog 3,6'-Dithiothalidomide on traumatic brain injury. Int J Mol Sci. 20(502)2019.PubMed/NCBI View Article : Google Scholar

39 

Tsai YR, Tweedie D, Navas-Enamorado I, Scerba MT, Chang CF, Lai JH, Wu JC, Chen YH, Kang SJ, Hoffer BJ, et al: Pomalidomide reduces ischemic brain injury in rodents. Cell Transplant. 28:439–450. 2019.PubMed/NCBI View Article : Google Scholar

40 

Baratz R, Tweedie D, Wang JY, Rubovitch V, Luo W, Hoffer BJ, Greig NH and Pick CG: Transiently lowering tumor necrosis factor-α synthesis ameliorates neuronal cell loss and cognitive impairments induced by minimal traumatic brain injury in mice. J Neuroinflammation. 12(45)2015.PubMed/NCBI View Article : Google Scholar

41 

Secher N, Ostergaard L, Tonnesen E, Hansen FB and Granfeldt A: Impact of age on cardiovascular function, inflammation, and oxidative stress in experimental asphyxial cardiac arrest. Acta Anaesthesiol Scand. 62:49–62. 2018.PubMed/NCBI View Article : Google Scholar

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Palmer AA, Stezoski JP, Janesko‑Feldman K, Kochanek PM and Drabek T: Targeting TNFα‑mediated cytotoxicity using thalidomide after experimental cardiac arrest in rats: An exploratory study. Exp Ther Med 23: 380, 2022.
APA
Palmer, A.A., Stezoski, J.P., Janesko‑Feldman, K., Kochanek, P.M., & Drabek, T. (2022). Targeting TNFα‑mediated cytotoxicity using thalidomide after experimental cardiac arrest in rats: An exploratory study. Experimental and Therapeutic Medicine, 23, 380. https://doi.org/10.3892/etm.2022.11307
MLA
Palmer, A. A., Stezoski, J. P., Janesko‑Feldman, K., Kochanek, P. M., Drabek, T."Targeting TNFα‑mediated cytotoxicity using thalidomide after experimental cardiac arrest in rats: An exploratory study". Experimental and Therapeutic Medicine 23.6 (2022): 380.
Chicago
Palmer, A. A., Stezoski, J. P., Janesko‑Feldman, K., Kochanek, P. M., Drabek, T."Targeting TNFα‑mediated cytotoxicity using thalidomide after experimental cardiac arrest in rats: An exploratory study". Experimental and Therapeutic Medicine 23, no. 6 (2022): 380. https://doi.org/10.3892/etm.2022.11307
Copy and paste a formatted citation
x
Spandidos Publications style
Palmer AA, Stezoski JP, Janesko‑Feldman K, Kochanek PM and Drabek T: Targeting TNFα‑mediated cytotoxicity using thalidomide after experimental cardiac arrest in rats: An exploratory study. Exp Ther Med 23: 380, 2022.
APA
Palmer, A.A., Stezoski, J.P., Janesko‑Feldman, K., Kochanek, P.M., & Drabek, T. (2022). Targeting TNFα‑mediated cytotoxicity using thalidomide after experimental cardiac arrest in rats: An exploratory study. Experimental and Therapeutic Medicine, 23, 380. https://doi.org/10.3892/etm.2022.11307
MLA
Palmer, A. A., Stezoski, J. P., Janesko‑Feldman, K., Kochanek, P. M., Drabek, T."Targeting TNFα‑mediated cytotoxicity using thalidomide after experimental cardiac arrest in rats: An exploratory study". Experimental and Therapeutic Medicine 23.6 (2022): 380.
Chicago
Palmer, A. A., Stezoski, J. P., Janesko‑Feldman, K., Kochanek, P. M., Drabek, T."Targeting TNFα‑mediated cytotoxicity using thalidomide after experimental cardiac arrest in rats: An exploratory study". Experimental and Therapeutic Medicine 23, no. 6 (2022): 380. https://doi.org/10.3892/etm.2022.11307
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team